Skip to main content
HR 805 106th Congress House

Generic Drugs Access Act of 1999

Official title: To amend the Federal Food, Drug, and Cosmetic Act to establish therapeutic equivalence requirements for generic drugs, and for other purposes.

Introduced: February 23, 1999 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Health Administrative procedureCommunication in medicineDepartment of Health and Human ServicesDrug approvals
More subjectsShow fewer subjects
Federal preemptionGeneric drugsGovernment Operations and PoliticsGovernment paperworkGovernment publicityLawLocal lawsState laws
Sign in to write a letter Sign in to watch
This bill died when the 106th Congress ended
It never became law before the 106th Congress (1999–2000) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 11, 1999
Referred to the Subcommittee on Health and Environment.
Feb 23, 1999
Referred to the House Committee on Commerce.
Feb 23, 1999
Sponsor introductory remarks on measure. (CR E263)
Feb 23, 1999
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 11, 1999

Referred to the Subcommittee on Health and Environment.

 Plain-English summary Congressional Research Service

Generic Drugs Access Act of 1999 - Amends the Federal Food, Drug, and Cosmetic Act with respect to new drug applications to direct the Secretary of Health and Human Services to include in an application approval a finding about whether the approved (generic) drug is the therapeutic equivalent of the listed drug involved.

Prohibits a State or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Democratic 3
D
Nadler, Jerrold
New York · Feb 23, 1999
 D
Norton, Eleanor Holmes
District of Columbia · Feb 23, 1999
 D
Schakowsky, Janice D.
Illinois · Feb 23, 1999
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 805: Generic Drugs Access Act of 1999. 106th Congress. Open America. https://openamerica.io/bill/106-HR-805/
MLA
"H.R. 805: Generic Drugs Access Act of 1999." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-805/.
Bluebook (legal)
H.R. 805, 106th Cong. (2026), https://openamerica.io/bill/106-HR-805/.
Markdown link
[H.R. 805: Generic Drugs Access Act of 1999](https://openamerica.io/bill/106-HR-805/)
Report a problem